Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02780414 · ClinicalTrials.gov registry record
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
A clinical trial, sponsored by Progenity.
- Completed
- Registry status
- 1,730
- Enrollment target
NCT02780414: Completed study, sponsored by Progenity.
NCT02780414 is a clinical trial that has completed, run by Progenity. The registered enrollment target is 1,730 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02780414 has completed, sponsored by Progenity.
- COMPLETED
- Registry status
- 1,730 participants
- Enrollment target
Study Summary
Preeclampsia (Pre-E) is a hypertensive disease of pregnancy with multi-system involvement that usually occurs in the second half of pregnancy. Pre-E occurs in 5% to 7% of U.S. pregnancies, and is the third-leading cause of U.S. maternal death. Improvements to the current diagnostic paradigm have been evaluated. However, no stand-alone diagnostic method has emerged that more accurately identifies women at risk for preeclampsia, warranting improvements in diagnosing Pre-E. This sample collection study will obtain serum and urine samples from pregnant women who present with clinical signs, symptoms, or conditions contributing to the suspicion of Pre-E. Samples will be used to evaluate and validate the performance of an assay intended to aid in assessing the risk of Pre-E.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,730 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-10-23 |
What the finished NCT02780414 record still lists
NCT02780414 is an observational study that tracks outcomes without assigning an intervention. Its 1,730 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02780414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02780414 about?
NCT02780414 is a clinical study titled "Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers". Preeclampsia (Pre-E) is a hypertensive disease of pregnancy with multi-system involvement that usually occurs in the second half of pregnancy. Pre-E occurs in 5% to 7% of U.S. pregnancies, and is the third-leading cause of U.S. maternal death. Improvements to the current diagnostic paradigm have bee...
What is the current status of trial NCT02780414?
This trial is currently completed. The enrollment target is 1,730 participants. The study started on 2016-01. Estimated completion is 2020-10-23.
Who is sponsoring clinical trial NCT02780414?
This trial is sponsored by Progenity, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06413420 · 1,731 participants
SUNOSI® (Solriamfetol) Pregnancy Registry
- NCT06898034 · 1,725 participants
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
- NCT04712656 · 1,739 participants
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia